Less than six months after the world first learnt about the novel coronavirus (SARS-CoV 2) in Wuhan, China, there currently are more than 110 teams in contention, speeding up efforts to produce a ready vaccine. A lot of vaccines are in the development phase in India as well, and medicinal trials are also going on for treatment. The reason behind the rush is a staggering number of Covid-19 cases (past 6 million) and death toll (more than 350,000 globally). In India alone, there are 151,876 corona cases as of May 27. Large pharmaceutical companies such as Gilead Sciences, Pfizer, Moderna, among others, are racing to find a successful vaccine. In India, Ramdev's Patanjali has also joined the race to develop